Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Nov;91(11):4205-14.
doi: 10.1210/jc.2006-1645. Epub 2006 Aug 15.

Extensive clinical experience: nonclassical 21-hydroxylase deficiency

Affiliations
Review

Extensive clinical experience: nonclassical 21-hydroxylase deficiency

Maria I New. J Clin Endocrinol Metab. 2006 Nov.

Erratum in

  • J Clin Endocrinol Metab. 2007 Jan;92(1):142. Dosage error in article text

Abstract

Context: Nonclassical congenital adrenal hyperplasia (CAH) owing to steroid 21-hydroxylase deficiency (NC21OHD) is the most frequent of all autosomal recessive genetic diseases, occurring in one in 100 persons in the heterogeneous New York City population. NC21OHD occurs with increased frequency in certain ethnic groups, such as Ashkenazi Jews, in whom one in 27 express the disease. NC21OHD is underdiagnosed in both male and female patients with hyperandrogenic symptoms because hormonal abnormalities in NC21OHD are only mild to moderate, not severe as in the classical form of CAH. Unlike classical CAH, NC21OHD is not associated with ambiguous genitalia of the newborn female.

Main outcome measures: The hyperandrogenic symptoms include advanced bone age, early pubic hair, precocious puberty, tall stature, and early arrest of growth in children; infertility, cystic acne, and short stature in both adult males and females; hirsutism, frontal balding, polycystic ovaries, and irregular menstrual periods in females; and testicular adrenal rest tissue in males.

Conclusions: The signs and symptoms of hyperandrogenism are reversed with dexamethasone treatment.

PubMed Disclaimer

Publication types

Substances